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ABSTRACT  
Back ground: Respiratory Tract Infections (RTIs) often pose a major threat for geriatric patients (>60 years) who are at higher risk of 
developing complications. The first line treatments for RTIs are antibiotics which help in reducing the infection. As there is increasing incidence 
of antimicrobial resistance it is necessary to conduct drug utilization of antibiotics which helps in better understanding about errors and risks 
involved in prescriptions. 
Objectives: The objective of the study is to access the prescribing pattern, appropriate use of antibiotics and inappropriateness of antibiotics in 
viral infections. 
Methodology: The present study is a prospective observational study. The study included 110 patients which included the evaluation of the 
patients medical records of antibiotics, sputum culture reports and physician records.  
Results: Out of 110 geriartric RTI patients, female (59.09%) were more predominantly affected over males (40.90%). Among the RTIs 
diagnosed pneumonia (40%) was higher followed by LRTI (28.18%). The common signs and symptoms found were breathlessness (34.54%) 
with major comorbidity of diabetes milletus (47.31%). Piperacillin + tazobactam (40.90%) was the mostly prescribed antibiotic for both gram 
positive (Streptococci) and gram negative (E. coli) bacteria which was given through I.V. (90%). Total drug interactions and medication errors 
were 13.03% and 3.32% respectively. 
Conclusion: The present study gives an overview of antibiotics use and complications involved in geriatric population diagnosed with RTIs. 
Appropriate antibiotic usage according to Hospital Antibiotic Policy was observed in the study site with lower number of medication errors and 
drug interactions. 
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INTRODUCTION 
The respiratory tract constitutes a large body portion that is 
in contact with the outside environment. Although there are 
presences of non-pathogenic microbes found during 
microbiological testing, still the tract is considered to be 
sterile. Therefore an invasion of pathogenic micro-
organisms into the tract represents a series of threat that 
requires immediate immune responses1. In South-East 
region, of the total 3,941,000 deaths, Respiratory Tract 
Infections (RTIs) accounts for 34.60% deaths2. 
In most of the developing countries, the burdens of RTIs are 
largely unknown3. RTIs account for more restricted activity 
and loss of time from work than any other category of 
infections4. Exposure of variable individuals to infectious 
agents, infectious dose and pathogen virulence drive 
differences in the frequency of respiratory infections. The 
rating of infectious disease risk depends on several 
environmental factors and lifestyle habits5. Infectious 
respiratory diseases include common cold, bronchitis, 
bronchiolitis, pneumonia, tuberculosis whereas non 
infectious respiratory diseases include chronic obstructive 
pulmonary disease, asthma, occupational lung disease and 
pulmonary malignancies. 
There are mainly of two types of infectious respiratory 
disease: upper and lower respiratory tract infections. Upper 
Respiratory Tract Infection (URTI) is a nonspecific term 
which is used to describe acute infections that involves nose, 
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paranasal sinuses, pharynx, larynx, trachea and bronchi.This 
can lead to illnesses such as common cold, tonsillitis, 
pharyngitis, laryngitis, sinusitis, otitis media that constitute 
87.5% of the total episodes of respiratory infections. On the 
other hand Lower Respiratory Tract Infection (LRTI) 
comprises of acute bronchitis, acute exacerbation of chronic 
bronchitis, pneumonia and pleurisy6. In a systematic 
analysis conducted in 2015, LRTIs caused 2.74 million 
deaths and 103 million Disability Adjusted Life-Years 
worldwide (DALYs) making them the second leading cause 
of DALYs7. 
Lack of relevant information about etiological agents results 
in inappropriate use of drugs. Therefore, the detection of a 
potentially causative agent forms the prerequisite for proper 
treatment and an early detection of virus can reduce the 
rates of irrational and overuse prescription. Due to the 
emergence of an increasing number of multi-drug resistant 
bacteria, respiratory infections due to bacterial origin have 
become a global concern8. Antibiotics are the oldest class of 
drugs that fight against specific micro organisms like 
bacteria and fungi9. There are more than 100 million 
antibiotic prescriptions in an adult ambulatory care hospital 
set up per year, out of these 41% are for respiratory 
conditions10. 
As age increases, frequent health related issues also arise 
and that include frailty, polypharmacy, under use of 
medication, inappropriate prescribing, medication errors, 
comorbidity conditions, pharmacokinetic and 
pharmacodynamics changes affecting the absorption, 
distribution, metabolism and excretion of drugs11. 
Another area of concern is seen in medication errors with 
respect to prescriptions. According to NCC MERP, 
Medication Error (ME) is defined as “any preventable event 
that may cause or lead to inappropriate medication use or 
patient harm while the medication is in control of the health 
care professional, patient, or consumer. Such events may be 
related to professional practice, health care products, 
systems and procedures, including prescribing, order 
communication, product labelling, packaging, nomenclature, 
compounding, dispensing, distribution, administration, 
education, monitoring and use12. 
Drug Utilization Review (DUR) is defined as an authorized, 
structured, ongoing review of prescribing, dispensing and 
use of medication. Drug utilization studies play a major in 
our health care system and it also provides a view about the 
efficiency of drug use. As a result they help us to set up 
priorities for rational use of antibiotics and health care 
budgets. In India there is no sufficient data which gives 
insight about the respiratory tract infection, resistance 
patterns and proper guidelines for rational use of antibiotics. 
So DUR studies provide information about prescribing 
antibiotics for even mild cases, selling the antibiotics over 
the counter without prescriptions. It helps to generate a 
relevant data regarding the issues present currently13. 
The purpose of the study is to determine average number of 
antibiotics prescribed per prescription, to identify the 
indication for which antibiotics were commonly used and to 
determine the most commonly prescribed antibiotic in 
respiratory infections in a secondary care hospital14. 
Objectives: 
Primary objectives 
 To carry out drug utilization review of antibiotics in 
respiratory tract infections among geriatrics in a 
secondary care hospital. 
 To provide effective management suggestions based on 
the study results for improved health care in geriatrics. 
Secondary objectives 
 To access the pattern of antimicrobial drug utilization 
among geriatric patients in the current study site. 
 To foster the appropriate use of antibiotics for 
respiratory tract infections. 
MATERIALS AND METHODS 
Study site: 
Excel Care Multispecialty Hospital, Bengaluru, Karnataka, 
India. 
Study design: 
A prospective observational hospital based study. 
Study period: 
Carried out for a period of six months. 
Inclusion criteria 
o Both male and female patients of age 60 years and 
above. 
o Patients diagnosed with respiratory tract infections. 
o Patients who are prescribed with antibiotics. 
Exclusion criteria 
o Patients under the age of 60 years. 
o Patients who stay less than 24 hours in the hospital. 
o Accident cases and patients with altered 
consciousness. 
o Patients diagnosed with pulmonary malignancies and 
occupational lung diseases. 
Source of data: 
Patient’s case notes. 
Study procedure: 
A prospective observational study was conducted in the 
pulmonary department of Excel Care Multi-Specialty 
hospital by obtaining approval from the hospital for a period 
of 6 months. A specially planned case reporting performa 
was designed to collect data such as demographics, 
diagnosis, current complaints, past medical and medication 
history, known allergies, laboratory reports (chest X-ray), 
full antibiotics received, antibiotics prescribed on admission, 
route of antibiotic administration, duration of antibiotics 
given to the patient throughout his/her hospital stay was 
collected. 
The collected data was analyzed for the age and gender 
distribution, number of comorbidities, route of 
administration, distribution of RTIs, average number of 
antibiotics prescribed per prescription, most prescribed 
antibiotic, drug interactions through Micromedex drug 
interaction app, adverse drug reactions and medication 
errors. 
Result analysis: 
The collected data was subjected to Descriptive Statistical 
Analysis using Microsoft Excel. 
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RESULTS 
A prospective observational study was conducted over a 
period of 6 months at Excel Care Multispeciality Hospital, 
Bengaluru. During the study, 110 geriatric patients were 
enrolled diagnosed with respiratory tract infections. 
Table 1: Gender distribution 
Gender No. of prescriptions Percentage (%) 
Male 45 40.90 
Female 65 59.09 
Total 110 100 
 
Table 1 depicts that; out of 110 patients involved, the 
percentage of female (59.09%) was found to be more. when 
compared to males (40.90%). Therefore, females were found 
to be the predominant gender. 
From the Table 2; age groups between 60-79 are more prone 
to incidence of respiratory tract infections. 
As seen in Table 3; pneumonia was found to be the major 
type of respiratory infection involved with a total of 44 
(40%) cases and least was with Bronchiectasis with 2 
(1.81%) cases. 
Table 2: Distribution of patients according to age (in 
years) group 
Age No. of prescritions Percentage 
60-69 40 36.36% 
70-79 41 37.27% 
80-89 23 20.90% 
90-100 6 5.45% 
Total 110 100% 
 
Table 3: Distribution of patients according to the type of 
RTI 
Distribution of RTIs No. of patients Percentage (%) 
Pneumonia 44 40 
LRTI 31 28.18 
COPD 16 14.54 
Viral Pneumonia 5 4.54 
Bronchial Asthma 3 2.72 
Bronchiectasis 2 1.81 
 
Table 4 represents that breathlessness (34.54%) was the 
frequent problem that the patients faced. 
 
Table 4: Signs and symptoms 
Signs and symptoms No. of patients affected Percentage (%) 
Breathlessness 38 34.54 
Cough with expectoration 28 25.45 
Wheezing 17 15.45 
Cough with Whitish sputum 13 11.81 
Cough with yellowish sputum 10 9.09 
Fever 9 8.18 
Cold 8 7.02 
Throat irritation 3 2.72 
Cough with greenish sputum 3 2.72 
 
Table 5: Gram positive bacteria 
Gram positive bacteria No. of patients Percentage 
Streptococci 10 9% 
 
Table 6: Gram negative bacteria 
Gram negative bacteria No. of patients Percentage 
E. coli 8 7.27% 
Pseudomonas aeruginosa 7 6.36% 
Influenza H1N1 6 5.45% 
Klebsiella pneumonia 5 4.50% 
Total 23.58% 
 
From Table 6; the gram-negative E. coli bacteria was found to be higher 8 (7.27%) followed by Pseudomonas aeruginosa 7 
(6.36%). The distribution of gram-negative bacteria was more common than gram-positive bacteria. 
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From Table 7 and Figure 1; the infection due to both gram-positive and gram-negative bacteria was most commonly treated 
with Piperacillin/Tazobactam (7). 
Table 7: Distribution of antibiotic therapy in accordance with respective isolated organisms 
 
 
Figure 1: Distribution of antibiotics and isolated organism 
 
From Table 8; 51 (46.36%) prescriptions had one 
antibiotic, followed by 38 (34.54%) prescriptions with 2 
antibiotics, 15 (13.63%) prescriptions with 3 antibiotics, 5 
(4.54%) prescriptions with 4 and prescriptions with 5 
antibiotics was found only 1 (0.90%), which was the 
maximum number prescribed throughout the hospital stay. 
Table 8: Number of antibiotics per prescription 
No. of antibiotics No. of prescriptions Percentage 
1 51 46.36% 
2 38 34.54% 
3 15 13.63% 
4 5 4.54% 
5 1 0.90% 
Total 110 100% 
 
The commonly prescribed antibiotic under RTI was found 
out by counting the total number of antibiotic and 
classifying them into the respective drug classes. From 
Table 9 and Figure 2 Piperacillin + Tazobactam 
combination (39) was the most prescribed Antibiotic 
under RTI, followed by doxycycline (21). 
Table 9: Commonly prescribed antibiotics 
Antibiotics No. of 
antibiotics 
Percentage 
Piperacillin + Tazobactam 39 35.45% 
Doxycycline 21 19.09% 
Clarithromycin 15 13.63% 
Cefoperazone + Sulbactam 14 12.72% 
Amoxicillin + Clavulanate 8 7.27% 
Levofloxacin 8 7.27% 
Ceftriaxone 6 5.45% 
Meropenam 5 4.54% 
Cefixime 4 3.63% 
Cefuroxime 4 3.63% 
Cefotaxim 3 2.72% 
Azithromycin 3 2.72% 
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 ANTIBIOTICS  AND ORGANISMS  
Streptococci Pseudomonas aeruginosa H1N1 influenza E.coli Klebsiella pneumonia
Antibiotics Streptococci Pseudomonas 
aeruginosa 
H1N1 
influenza 
E. coli Klebsiella 
pneumonia 
Piperacillin/Tazobactam 7  4 3 5 
Cefoperazone/Salbactam 3 3  1  
Ceftriaxone    1  
Cefixime  1    
Cefipime  1    
Clarithromycin     2 
Azithromycin  1    
Doxycycline  1   1 
Colistimethate sodium  1    
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Figure 2: Commonly prescribed antibiotics 
Table 10: Number of antibiotic + antibiotic interactions observed in the study 
Antibiotic + antibiotic 
interactions 
Total no. of prescriptions  Percentage 
13 110 11.81% 
 
As seen in Table 10 and Figure 3; the number of interactions between antibiotics was found to be less i.e., out of 110 
prescriptions the interactions were 13 (11.81%). 
 
Figure 3: Number of antibiotic + antibiotic interactions in the study 
 
Table 11: Number of antibiotic + other drug interactions observed in the study 
Antibiotic + other drug 
interaction 
No. of prescriptions (110) Percentage 
Major 32 29.09% 
Moderate 8 7.27% 
Minor 5 4.50% 
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Figure 4: Number of antibiotic + other drug interactions 
in the study 
From the Table 11 and Figure 4; the maximum drug 
interactions observed were Major 32 (29.09%) in nature, 
followed by moderate, and minor. Moderate interactions 
were 8 (7.27%) in number and Minor were 5 (4.50%) in 
number. 
Table 12: Number of medication errors in the study 
Medication 
errors 
No. of 
prescriptions 
Percentage 
Dose 6 5.45% 
Frequency 3 2.72% 
ROA 2 1.81% 
Average = 3.32% 
 
Evidence from Table 12, suggests that in the current study 
the number of prescriptions with medical error was less and 
the percentage of ME was 3.32%. 
Table 13 depicts that bronchodilators (81.81%) were the 
most prescribed class of drugs other than antibiotics 
followed by anti-diabetes (40%). 
Table 13: Class of drugs other than antibiotics 
Class of drugs No. of prescriptions Percentage (%) 
Anti-virals 10 9.09 
 
DISCUSSION 
Older patients are addressed with more respiratory 
infections when compared with younger populations. 
Antibiotics being the first line treatment in respiratory tract 
infections that combat specific micro organisms; the more 
consumption of the drug increases its resistance that 
becomes a major threat to public health. This requires the 
pharmacist to intervene and develop strategies aimed 
towards better patient care and improving the quality of life 
of the patients, especially special populations like the 
geriatrics. As shown in Table 2, in the current study; out of a 
total number of 110 prescriptions analysed, females showed 
higher percentage 65 (59.09%) occurrence of RTI when 
compared to male 45 (40.09%). Therefore, females are more 
predominant and from Table 1; age groups between 60-79 
showed more incidence RTIs. 
E Hak, Rovers15 et.al. shared same evidence on their study 
on Incidence of GP-diagnosed Respiratory Tract Infections 
according to age, gender and high risk morbidity. The 
incidence rates of RTIs were higher in females 103 than in 
males 74 per 1000 patients. 
All the patient profile forms were analysed to find the major 
type of RTI responsible for hospital admission. From Table 3 
Pneumonia was found to be the major type of infection 
involved with a total of 44 (40%) cases presented with a 
common symptom of breathlessness (34.54%) followed by 
cough with expectoration (25.45%) as shown in Table 4. 
A study conducted on Pneumonia and Hospitalizations in the 
Elderly by Francessco Cacciatore et.al. showed higher 
incidence of Pneumonia in geriatrics when compared to all 
other RTIs. The study showed 25-44 per 1000 cases with an 
incidence of Community Acquired Pneumonia16. 
From Table 6; the distribution of gram-negative E. coli 
(7.27%) bacteria was found to be higher. The prevalence of 
gram-negative bacteria causing infection was more 
significant compared to gram-positive bacteria as shown in 
Table 5; Piperacillin/Tazobactam was the most commonly 
prescribed antibiotic for both gram-positive (Streptococci) 
and gram-negative (E. coli). 
As shown in Table 8; of the total number of prescriptions 
(110), 51 (46.36%) prescriptions had one antibiotic, 
followed by 38 (34.54%) prescriptions with 2 antibiotics, 15 
(13.63%) prescriptions with 3 antibiotics, 5 (4.54%) 
prescriptions with 4 and with 5 antibiotics was found only 1 
(0.90), which was the maximum number of antibiotics 
prescribed throughout the hospital stay. 
In the current study the commonly prescribed antibiotic 
under RTI was found out by counting the total number of 
antibiotic and classifying them into respective drug classes. 
From Table 9 and Figure 2, Piperacillin+Tazobactam 39 
(35.45%) was the commonly prescribed combination drug 
and doxycycline 21(19.09%) was the commonly prescribed 
monotherapy belonging to the class of Penicillins+β-
Lactamase inhibitor and tetracyclines respectively. 
Penicillin+b-lactamase inhibitors have activity against many 
gram-positive and gram-negative bacteria. 
The number of interactions between the antibiotics was 
found to be less i.e., out of 110 prescriptions, Antibiotic 
interactions were 13 (11%) from Table 10 and Figure 3. The 
most commonly found interactions were between 
Piperacillin/Tazobactam and Doxycycline. This interaction 
can lead to decreased antibacterial effectiveness, so 
monitoring is advised. 
From Table 11 and Figure 4; the maximum drug interactions 
observed were major 32 (29.09) in nature, followed by 
moderate and minor. Moderate interactions were 8 (7.27%) 
and minor were 5 (4.50%) in number. 
The NCC MERP has classified medication error into 9 classes 
as depicted by the above figure. In our study, 11 medication 
errors were found in total. The event of not prescribing the 
Dose occurred in a total of 6 (5.45%) cases, while the event 
of not prescribing the frequency occurred in a total of 3 
(2.72%) cases and Route of Administration 2 (1.81%) as 
shown in Table 12. According to NCC MERP classification, 
these events fall under the Category A (Circumstances or 
events that have the capacity to cause error). 
Oseltamivir (9.09%) was the drug that has been given to 
patients diagnosed with viral infections other than 
antibiotics as shown in Table 13. 
Kevin T Shiley, MD et.al. from their study on the use of 
antimicrobial agents after diagnosis of Viral Respiratory 
Tract Infections has shown that Oseltamivir was given to 30 
0
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(21%) out of 142 patients with influenza. Our study suggests 
that there is a necessity to monitor medication errors like 
frequency, dose and route of administration of antibiotics 
though errors are minimal. Out of total prescriptions 
evaluated, the percentages of drug interactions were found 
to be very low. Even though the number of errors and 
interactions are less, still strict monitoring is advised to 
eliminate the possible RI17. 
CONCLUSION 
A prospective observational study on drug utilization of 
antibiotics was successfully carried out in 110 geriatric 
patients diagnosed with Respiratory Tract Infections. In our 
study the most commonly prescribed antibiotic was 
Piperacillin and tazobactam. 
Based on the current antibiotic policy of the hospital in 
which the study was conducted the first line antibiotic 
agents are Piperacillin/tazobactam and cephalosporins of 
higher generations; the second line antibiotics were 
Amoxicillin/clavulanic acid if penicillin allergy is present, 
Macrolides and other alternatives are Cephalosporins. In 
case of previous antibiotic resistance detected Meropenem is 
prescribed by previous culture reports. The study shows 
evidence that the medical practitioners are strictly adhering 
to Hospital Antibiotic Policy in prescribing antibiotics. 
Though in the current study the percentage of 
drug interactions and medication errors were low still 
proper evaluation is required. This is done by collecting 
complete and correct data so that the right medication can 
be prescribed for the indicated condition, all the 
prescriptions must be thoroughly checked for medication 
errors, drug interactions; also correct dose, frequency and 
ROA must be clearly mentioned for every prescription. This 
may sometime lead to other unnecessary complications. 
Limitations 
 The period of study was six months which was very 
limited to carryout observations in a wider aspect. 
 Information on anti-viral agents was limited. 
Future Directions 
 The study can be carried out in a larger population by 
creating multiple study sites. 
 Antimicrobial susceptibility testing could give a better 
overview on newer or emerging antimicrobial 
resistance. 
 Using the study results hospital antibiotic drug policy 
can be framed. 
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